Why Sell Abbott Labs? Here Are 3 Reasons to Consider

In this video, Fool bureau chief Brenton Flynn offers three reasons why you might take a pass on Abbott Labs. The company reduced its dividend after spinning off AbbVie, which reduces its appeal to income investors. The loss of AbbVie means Abbott will have to work harder at improving its earnings since its branded pharmaceutical business isn't there to roll out a blockbuster drug.

Follow along in the video below as Brenton details these bearish arguments.

Wondering about that new position in your portfolio? For some Abbott Labs shareholders, the new year brought with it a new company called AbbVie. Formerly Abbott's branded pharmaceuticals business, shares of the new stock were distributed to investors on Jan. 2. To help investors better understand the situation, The Fool has created a brand new premium report on both stocks. Inside, we outline all of the must-know opportunities and risks facing both companies, so make sure to claim this report by clicking here now.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2346843, ~/Articles/ArticleHandler.aspx, 4/24/2014 1:52:22 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 4 hours ago Sponsored by:
DOW 16,501.65 -12.72 -0.08%
S&P 500 1,875.39 -4.16 -0.22%
NASD 4,126.97 0.00 0.00%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

4/23/2014 4:01 PM
ABT $38.60 Down +0.00 +0.00%
Abbott Laboratorie… CAPS Rating: *****

Advertisement